Related Experiment Videos

The Drosophila wing test: a comparison of the sensitivity of different strains

J Clements1, D Howe, M Phillips

  • 1Department of Biology, University of York, Heslington, Great Britain.

Mutation Research
|April 1, 1988
PubMed

Insights

Five chemical mutagens, including alkylating agents and anti-cancer drugs, were tested in the Drosophila wing test. Different genetic backgrounds in two strains led to significant variations in their responses to these mutagens.

Area of Science:

  • Toxicology and genetics
  • Chemical mutagenesis research

Background:

  • The Drosophila wing test is a standard assay for detecting mutagenicity.
  • Understanding differential responses to mutagens is crucial for risk assessment.

Purpose of the Study:

  • To evaluate the mutagenic potential of five chemical agents using the Drosophila wing test.
  • To investigate strain-specific variations in mutagen sensitivity.

Main Methods:

  • Utilized the Drosophila wing test with two distinct genetic strains.
  • Administered five chemical mutagens: methyl methanesulfonate (MMS), N-ethyl-N-nitrosourea (ENU), methotrexate, cytosine-arabinoside, and adriamycin.
  • Conducted parallel experiments under standardized conditions.

Main Results:

  • Observed significant variations in mutagenic responses between the two Drosophila strains.
  • Demonstrated differential sensitivity to the tested chemical mutagens based on genetic background.
  • Identified specific patterns of response to alkylating agents and anti-cancer drugs.

Conclusions:

  • Genetic background plays a critical role in modulating sensitivity to chemical mutagens.
  • The Drosophila wing test effectively highlights inter-strain variability in mutagenic responses.
  • Findings contribute to a better understanding of chemical mutagen toxicity and genetic susceptibility.

Related Concept Videos